edison

Edison Oncology和冠科美博（Apollomics）宣布EO1001(APL-122) I/IIa 期临床试验中首例患者接受治疗

tallulah 1 10 月

1 minute

MENLO PARK, Calif., FOSTER CIT […]...

Edison Oncology and Apollomics Announce Treatment of First Patient with EO1001 (APL-122) in a Phase I/IIa Clinical Trial

indie 1 10 月

5 minutes

MENLO PARK, CA and HELSINKI, F […]

Apollomics, Inc. and Edison Oncology Announce Licensing Agreement for Novel Protein Tyrosine Kinase Inhibitor Targeting Solid Tumors

indie 10 2 月

4 minutes

FOSTER CITY, Calif. and HANGZH […]

Copyright © 2020 ASEANPR.Com All rights reserved.